Osteopore Limited (ASX:OSX)

Market Cap	2.43M -14.7%
Revenue (ttm)	2.93M +2.9%
Net Income	-3.97M
EPS	-0.01
Shares Out	693.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Open	0.0030
Previous Close	0.0035
Day's Range	0.0030 - 0.0030
52-Week Range	0.0030 - 0.0290
Beta	0.03
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and tra...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2025, Osteopore's revenue was 3.06 million, an increase of 10.65% compared to the previous year's 2.76 million. Losses were -3.72 million, 11.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error